HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

L’Oreal Grows Its Mass Offering, Social-Media Prowess With NYX Buy

This article was originally published in The Rose Sheet

Executive Summary

L’Oreal’s acquisition of mass color brand NYX cosmetics could help improve the France-based firm’s performance in North America, where it has faltered of late.

You may also be interested in...



A L’Oreal First: H1 Asia Pacific Sales Equal North America Take

The France-based beauty giant is stepping up its advertising and promotional investments to target younger consumers in the region – particularly Chinese millennials increasingly receptive to luxury products – confident that growth rates won’t be leveling off any time soon.

L’Oreal May Prune Body Shop While Lauder ‘Pivots’ In New Beauty Climate

The world’s biggest beauty players are working to meet changing consumer preferences and shopping habits without forfeiting growth momentum. For L’Oreal, this means a possible sale of The Body Shop, while the Estee Lauder Companies is reinventing its retail presence and increasingly relying on smaller, flashier brands to drive growth.

Cosmetics Industry Awaits ‘Critical’ Safety Assessment Clarification Under China’s New Framework Reg

The China State Council’s January approval of an overarching Cosmetics Supervision and Administration Regulation promises to bring about long-awaited reforms. But draft regulations targeted for release in coming months will be key to the implementation of CSAR provisions, the Personal Care Products Council says.

Related Companies

UsernamePublicRestriction

Register

RS019084

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel